{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:23:04Z","timestamp":1785284584720,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.clindermatol.2009.03.003","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T10:22:17Z","timestamp":1260958937000},"page":"88-92","source":"Crossref","is-referenced-by-count":69,"title":["Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies"],"prefix":"10.1016","volume":"28","author":[{"given":"Luigi","family":"Naldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2009.03.003_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archderm.1949.01530030126015","article-title":"Squamous cell epithelioma and psoriasis","volume":"60","author":"Hannay","year":"1949","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib2","first-page":"141","article-title":"The Berkson bias in action","volume":"52","author":"Conn","year":"1979","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study","volume":"125","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1365-2133.2000.03782.x","article-title":"Skin disorders in relation to oral contraception and other factors, includingage, social class, smoking and body mass index. Findings in a large cohort study","volume":"143","author":"Vessey","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2007.06.020","article-title":"Smoking and the risk of psoriasis in women: Nurses' Health Study II","volume":"120","author":"Setty","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/archderm.143.12.1559","article-title":"Incidence and risk factors for psoriasis in the general population","volume":"143","author":"Huerta","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","article-title":"Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II","volume":"167","author":"Setty","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib8","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.0022-202x.2001.01520.x","article-title":"Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden","volume":"117","author":"Boffetta","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0190-9622(92)70244-A","article-title":"Malignant tumors in patients with psoriasis","volume":"27","author":"Olsen","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:CACO.0000016573.79453.ba","article-title":"Obesity and cancer risk among white and black United States veterans","volume":"15","author":"Samanic","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1523-1747.ep12464847","article-title":"members of the Photochemotherapy Follow-up Study. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients","volume":"91","author":"Stern","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archderm.139.11.1425","article-title":"Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom","volume":"139","author":"Gelfand","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/rccm.200703-415PP","article-title":"The healthy worker effect in asthma: work may cause asthma, but asthma may also influence work","volume":"177","author":"Le Moual","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000183757","article-title":"National Registries of Systemic Treatment for Psoriasis and the European \u2018Psonet Initiative","volume":"218","author":"Lecluse","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djn260","article-title":"Nonmelanoma skin cancer and risk for subsequent malignancy","volume":"100","author":"Chen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM198405033101805","article-title":"Cutaneous squamous-cell carcinoma in patients treated with PUVA","volume":"310","author":"Stern","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/1523-1747.ep12464137","article-title":"Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment","volume":"91","author":"Stern","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1523-1747.2003.12350.x","article-title":"The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study","volume":"121","author":"Nijsten","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archderm.134.12.1582","article-title":"Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis","volume":"134","author":"Stern","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2133.1999.03044.x","article-title":"Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis","volume":"141","author":"Hannuksela-Svahn","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archderm.134.5.595","article-title":"Consensus workshop on the toxic effects of long term PUVA therapy","volume":"134","author":"Morison","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib24","first-page":"834","article-title":"Treatment with UV-B for psoriasis and nonmelanoma skin cancer. A systematic review of the literature","volume":"135","author":"Pieternel","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-4632.2004.02186.x","article-title":"UVB phototherapy and skin cancer risk: a review of the literature","volume":"44","author":"Lee","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2133.2004.06128.x","article-title":"An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report","volume":"151","author":"Ibbotson","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2133.2008.08876.x","article-title":"Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review","volume":"160","author":"Prey","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib29","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C","article-title":"The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study","volume":"73","author":"Stern","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000249793","article-title":"Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study","volume":"167","author":"Nyfors","year":"1983","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib31","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.142.9.1132","article-title":"Lymphoma risk in psoriasis: results of the PUVA follow-up study","volume":"142","author":"Stern","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long term safety of Methotrexate monotherapy in rheumatoid arthritis patients: A systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2133.2005.06563.x","article-title":"Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks","volume":"152","author":"Naldi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2007-0251","article-title":"Malignancy after solid organ transplantation: an overview","volume":"13","author":"Zafar","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-200011270-00015","article-title":"Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study","volume":"70","author":"Naldi","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1034\/j.1600-6143.2001.10411.x","article-title":"Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population","volume":"1","author":"Molmenti","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/jcp.56.6.439","article-title":"Lymphoproliferative disorders in Oxford renal transplant recipients","volume":"56","author":"Bates","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(01)06179-7","article-title":"Squamous cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study","volume":"358","author":"Mercil","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib40","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1517\/17425250802525496","article-title":"Clinical immunotoxicity of therapeutic proteins","volume":"4","author":"Descotes","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.clinthera.2005.12.007","article-title":"An integrated analysis of thirteen trials summarising the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy","volume":"27","author":"Goffe","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2133.2008.08673.x","article-title":"Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials","volume":"159","author":"Brimhall","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-4632.2006.02777.x","article-title":"Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb randomized controlled trial","volume":"45","author":"Papp","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/j.1600-6143.2007.01845.x","article-title":"Pescovitz M,et al. A phase I\/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archderm.143.6.719","article-title":"Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis","volume":"143","author":"Tyring","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib46","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2009.03.003_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000083505","article-title":"A new era in the management of psoriasis? Promises and facts","volume":"210","author":"Naldi","year":"2005","journal-title":"Dermatology"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T14:56:16Z","timestamp":1544799376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X09000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0738081X09000492"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.03.003","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}